Salesforce Inc (NYSE: CRM) shares rallied 24% during the week, marking their strongest performance since August 2020. The software giant topped the S&P 500’s leaderboard for the period, driven by blockbuster second-quarter fiscal 2027 results and a deepened partnership with Anthropic.

The technical setup indicates the stock remains overbought, with the Relative Strength Index (RSI) at 80.30. CRM is trading 24.3% above its 20-day Simple Moving Average (SMA) of $199.98 and 24.2% above its 200-day SMA of $200.25. While the 20-day SMA is above the 50-day SMA, signaling bullish intermediate momentum, the 50-day SMA remains below the 200-day SMA, indicating the long-term trend is still repairing.

Earnings and Partnership Recap

The rally was fueled by Salesforce reporting Q2 revenue of $11.35 billion, an 11% year-over-year increase that beat the $11.32 billion estimate. Adjusted earnings per share reached $5.90, significantly exceeding the $3.27 consensus. The profit surge was largely driven by a $2.6 billion non-recurring gain on its stake in AI startup Anthropic.

Simultaneously, Salesforce and Anthropic launched "Claudeforce," an enterprise integration allowing sales staff to access Salesforce data within Anthropic’s Claude chatbot. The tool features 37 pre-built skills and "Enterprise Frontier Safeguards" for data privacy. CEO Marc Benioff highlighted that AI-related annual recurring revenue is approaching $4 billion. Shares jumped 22.6% on Thursday alone, as the results quieted concerns that AI agents would erode Salesforce’s seat-based licensing model.

Analyst Price Target Adjustments

Following the results, several Wall Street firms updated their forecasts:

• Citigroup maintained a Neutral rating, raising its price target to $233.
• JPMorgan kept an Overweight rating, raising its forecast to $265.
• Mizuho maintained an Outperform rating, raising its forecast to $265.
• BTIG analyst Allan Verkhovski raised his target from $255 to $300, citing a "narrative-changing quarter."
• Evercore ISI Group analyst Kirk Materne raised his target from $250 to $290.

Guidance and Outlook

Salesforce raised its full-year fiscal 2027 adjusted earnings guidance to a range of $16.67 to $16.71, up from $14.06 to $14.12. This represents a significant lift above the Street estimate of $14.16. Full-year revenue outlook was lifted to $46.1 billion to $46.4 billion. For the third quarter, the company expects revenue between $11.42 billion and $11.50 billion, with adjusted EPS projected at $3.42 to $3.44.

What the Numbers Show

The adjusted EPS beat was substantial, with actual earnings of $5.90 exceeding the $3.27 estimate by more than 80%. This divergence was primarily driven by the $2.6 billion non-recurring gain on the Anthropic stake, rather than operational leverage alone. Excluding this investment gain, the core operational performance still exceeded expectations but to a lesser degree. The simultaneous raise in full-year adjusted EPS guidance to a midpoint of roughly $16.69 indicates management confidence in sustained profitability improvements beyond this one-time event. With AI-related annual recurring revenue approaching $4 billion against total revenue of $11.35 billion, AI now constitutes a significant portion of the company’s recurring income base.

Market Reaction

Shares of Salesforce surged as much as 20% on Thursday following the results and partnership announcement. According to Benzinga Pro data, CRM stock price activity showed shares trading higher by 20.88% at $248.55 at the time of publication. Later updates indicated shares had risen by 22.03% to $250.91. On Friday, shares faced minor downward consolidation, dipping 1.04% to $249.44 in premarket trading. Nasdaq futures were down 0.08% while S&P 500 futures gained 0.14% on Friday.

Salesforce (NYSE: CRM) has generated an average annual return of 17.13% over the past 20 years, outperforming the broader market by 7.93% on an annualized basis.

The company currently holds a market capitalization of $189.60 billion. This long-term performance underscores the significant impact of compounded returns on investment growth over extended periods.

Investment Growth Illustration

To contextualize this performance, an investor who purchased $100 of CRM stock 20 years ago would hold shares worth $2,390.93 today. This valuation is based on a share price of $231.50 at the time of writing.

What the Numbers Show

The divergence between the absolute growth of the initial investment and the annualized rate highlights the non-linear nature of compound interest. While the annualized figure suggests steady growth, the final value of $2,390.93 from a $100 base demonstrates how consistent outperformance against the market benchmark accumulates substantial capital over a two-decade horizon.